Tgd
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
120 3rd Ave S, Edmonds, Washington, 9802...Website
wearetgd.comRevenue
<$5 MillionIndustry
About Tgd
Tgd Org Chart
Is Tgd your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Tgd had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Tgd, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Tgd recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Tgd
Product Launch: Get notified when Tgd launches new products
Funding: Get notified immidiatlly once Tgd has new funding data
Check if Tgd has recently received funding, and reach out quickly before it becomes old news!
Check out if Tgd is spiking on competitors!
Recommended Actions
Find VP level buyers at Tgd
Find more new buyers
Company Profile Activity
Activity Insights
Tgd is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tgd is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tgd.
Tgd Tech Stack
A closer look at the technologies used by Tgd
Tgd News & Media
Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
Director Gregory Bailey has recently increased his stake in Biohaven Ltd (NYSE:BHVN) by purchasing 48,780 shares of the company's stock, according to a SEC Filing dated 2024-04-22.Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
NEW HAVEN, Conn., April 22, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology, today announced the...Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
NEW HAVEN, Conn., April 18, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology, today announced the...Biohaven Announces Proposed Public Offering of Common Shares
NEW HAVEN, Conn., April 17, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience and oncology, today announced that...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tgd
We are a force of creative minds with a talent for narrative, design, and experiences. TGD is formerly Ten Gun Design, soon to be something else. Stay tuned.... Read More